Elite Pharmaceuticals Inc (ELTP)

[cadillac107]

There are many fine, young, and aspiring biotech. companies around, some of which will reward their investors immensely, more than likely due to M&A activity. I just don't think that this is going to be one of them. Besides, as you pointed out, your valuable trading capital is being tied up (opportunity cost).


The bottom line, imo, is that I just don't see anything uniquely special in their work that is going to excite the investing public, and I personally feel one would be better off in other medical speculative opportunities (perhaps a newer medical technology). GLTU.